The neuropathogenesis of HIV-associated dementia (HAD) involves a complex interaction between viral proteins, glial cells (microglia and astrocytes), and mediators (cytokines/chemokines and neurotoxins). A growing body of epidemiological, histopathological, and molecular evidence indicates that substances of abuse, such as, opiates and cocaine, foster development of this devastating brain disorder. However, in contrast to opiates, which have high affinity for mu-opioid receptors, kappa-opioid receptor (KOR) ligands have been shown to have neuroprotective effects. The primary hypothesis underlying the research proposed in this grant application is that KOR ligands have a beneficial influence on HIV-1-related brain disease due to their inhibitory effects on neuropathogenic mechanisms of microglia and astrocytes. Based upon a substantial literature indicating that KOR ligands block responses to cocaine, a secondary hypothesis of this research project is that cocaine has a deleterious influence on HIV-1-related brain disease due to its potentiating effects on neuropathogenic mechanisms of microglia and astrocytes and that KOR ligands will block these effects of cocaine. To test these hypotheses, experiments have been designed using several human cell culture models (and functional assays) that are relevant to HIV-1 neuropathogenesis: microglial cells (expression of HIV-1 and neuropathogenic mediators), astrocytes (chemokine production and glutamate uptake), mixed neuronal/glial cells (apoptosis) and neural progenitor cells (proliferation, differentiation, and migration). In the experiments planned, the effects of selected KOR ligands, some of which have shown promise for treatment of cocaine addiction, will be compared to cocaine, and the inhibitory effects of KOR ligands on cocaine will be assessed. Major emphasis will be placed on defining the mechanisms underlying the effects of KOR ligands and cocaine and mechanisms whereby KOR ligands block the neuropathogenic effects of cocaine. Based upon the results of preliminary studies, the research proposed will yield new insights into these mechanisms and as a result this research project will foster the long-term goal of discovering new interventions for the prevention and treatment of HAD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA009924-11
Application #
6869501
Study Section
NeuroAIDS and other End-Organ Diseases Study Section (NAED)
Program Officer
Sharp, Charles
Project Start
1995-07-01
Project End
2005-08-31
Budget Start
2005-02-01
Budget End
2005-08-31
Support Year
11
Fiscal Year
2005
Total Cost
$117,589
Indirect Cost
Name
Minneapolis Medical Research Fdn, Inc.
Department
Type
DUNS #
068195064
City
Minneapolis
State
MN
Country
United States
Zip Code
55415
Sheng, Wen S; Hu, Shuxian; Herr, Greg et al. (2007) Human neural precursor cells express functional kappa-opioid receptors. J Pharmacol Exp Ther 322:957-63
Shideman, C R; Hu, S; Peterson, P K et al. (2006) CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism. J Neurosci Res 83:1471-84
Hu, Shuxian; Cheeran, Maxim C-J; Sheng, Wen S et al. (2006) Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells. J Pharmacol Exp Ther 318:1280-6
Clark 3rd, J P; Sampair, Christopher S; Kofuji, Paulo et al. (2005) HIV protein, transactivator of transcription, alters circadian rhythms through the light entrainment pathway. Am J Physiol Regul Integr Comp Physiol 289:R656-62
Cheeran, Maxim C-J; Hu, Shuxian; Ni, Hsiao T et al. (2005) Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J Neurosci Res 82:839-50
Sheng, Wen S; Hu, Shuxian; Ni, Hsiao T et al. (2005) TNF-alpha-induced chemokine production and apoptosis in human neural precursor cells. J Leukoc Biol 78:1233-41
Ni, Hsiao T; Hu, Shuxian; Sheng, Wen S et al. (2004) High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev Brain Res 152:159-69
Rock, R Bryan; Gekker, Genya; Hu, Shuxian et al. (2004) Role of microglia in central nervous system infections. Clin Microbiol Rev 17:942-64, table of contents
Gekker, Genya; Hu, Shuxian; Wentland, Mark P et al. (2004) Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells. J Pharmacol Exp Ther 309:600-6
Rogers, Thomas J; Peterson, Phillip K (2003) Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol 24:116-21

Showing the most recent 10 out of 50 publications